About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Anti-Inflammatory Therapeutics Market Size, Trends & Growth Report | 2032
Anti-Inflammatory Therapeutics Market
Anti-Inflammatory Therapeutics Market

Anti-Inflammatory Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Biologics), By Indications (Arthritis, Psoriasis, Respiratory Diseases, Multiple Sclerosis, Anti-inflammatory Bowel Disease, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI3398DR
Last Updated : Jun 19, 2024
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Anti-Inflammatory Therapeutics Market, By Drug Class (2020-2030)
    1. Nonsteroidal Anti-Inflammatory Drugs
    2. Corticosteroids
    3. Biologics
  2. Anti-Inflammatory Therapeutics Market, By Indications (2020-2030)
    1. Arthritis
    2. Psoriasis
    3. Respiratory Diseases
    4. Multiple Sclerosis
    5. Anti-inflammatory Bowel Disease
    6. Others
    1. North America
      1. North America Anti-Inflammatory Therapeutics Market, By Drug Class
        1. Nonsteroidal Anti-Inflammatory Drugs
          1. Corticosteroids
            1. Biologics
            2. North America Anti-Inflammatory Therapeutics Market, By Indications
              1. Arthritis
                1. Psoriasis
                  1. Respiratory Diseases
                    1. Multiple Sclerosis
                      1. Anti-inflammatory Bowel Disease
                        1. Others
                        2. U.S.
                          1. U.S. Anti-Inflammatory Therapeutics Market, By Drug Class
                            1. Nonsteroidal Anti-Inflammatory Drugs
                              1. Corticosteroids
                                1. Biologics
                                2. U.S. Anti-Inflammatory Therapeutics Market, By Indications
                                  1. Arthritis
                                    1. Psoriasis
                                      1. Respiratory Diseases
                                        1. Multiple Sclerosis
                                          1. Anti-inflammatory Bowel Disease
                                            1. Others
                                          2. Canada
                                        2. Europe
                                          1. Europe Anti-Inflammatory Therapeutics Market, By Drug Class
                                            1. Nonsteroidal Anti-Inflammatory Drugs
                                              1. Corticosteroids
                                                1. Biologics
                                                2. Europe Anti-Inflammatory Therapeutics Market, By Indications
                                                  1. Arthritis
                                                    1. Psoriasis
                                                      1. Respiratory Diseases
                                                        1. Multiple Sclerosis
                                                          1. Anti-inflammatory Bowel Disease
                                                            1. Others
                                                            2. U.K.
                                                              1. U.K. Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                1. Nonsteroidal Anti-Inflammatory Drugs
                                                                  1. Corticosteroids
                                                                    1. Biologics
                                                                    2. U.K. Anti-Inflammatory Therapeutics Market, By Indications
                                                                      1. Arthritis
                                                                        1. Psoriasis
                                                                          1. Respiratory Diseases
                                                                            1. Multiple Sclerosis
                                                                              1. Anti-inflammatory Bowel Disease
                                                                                1. Others
                                                                              2. Germany
                                                                              3. France
                                                                              4. Spain
                                                                              5. Italy
                                                                              6. Russia
                                                                              7. Nordic
                                                                              8. Benelux
                                                                              9. Rest of Europe
                                                                            2. APAC
                                                                              1. APAC Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                  1. Corticosteroids
                                                                                    1. Biologics
                                                                                    2. APAC Anti-Inflammatory Therapeutics Market, By Indications
                                                                                      1. Arthritis
                                                                                        1. Psoriasis
                                                                                          1. Respiratory Diseases
                                                                                            1. Multiple Sclerosis
                                                                                              1. Anti-inflammatory Bowel Disease
                                                                                                1. Others
                                                                                                2. China
                                                                                                  1. China Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                                    1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                                      1. Corticosteroids
                                                                                                        1. Biologics
                                                                                                        2. China Anti-Inflammatory Therapeutics Market, By Indications
                                                                                                          1. Arthritis
                                                                                                            1. Psoriasis
                                                                                                              1. Respiratory Diseases
                                                                                                                1. Multiple Sclerosis
                                                                                                                  1. Anti-inflammatory Bowel Disease
                                                                                                                    1. Others
                                                                                                                  2. Korea
                                                                                                                  3. Japan
                                                                                                                  4. India
                                                                                                                  5. Australia
                                                                                                                  6. Taiwan
                                                                                                                  7. South East Asia
                                                                                                                  8. Rest of Asia-Pacific
                                                                                                                2. Middle East and Africa
                                                                                                                  1. Middle East and Africa Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                                                    1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                                                      1. Corticosteroids
                                                                                                                        1. Biologics
                                                                                                                        2. Middle East and Africa Anti-Inflammatory Therapeutics Market, By Indications
                                                                                                                          1. Arthritis
                                                                                                                            1. Psoriasis
                                                                                                                              1. Respiratory Diseases
                                                                                                                                1. Multiple Sclerosis
                                                                                                                                  1. Anti-inflammatory Bowel Disease
                                                                                                                                    1. Others
                                                                                                                                    2. UAE
                                                                                                                                      1. UAE Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                                                                        1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                                                                          1. Corticosteroids
                                                                                                                                            1. Biologics
                                                                                                                                            2. UAE Anti-Inflammatory Therapeutics Market, By Indications
                                                                                                                                              1. Arthritis
                                                                                                                                                1. Psoriasis
                                                                                                                                                  1. Respiratory Diseases
                                                                                                                                                    1. Multiple Sclerosis
                                                                                                                                                      1. Anti-inflammatory Bowel Disease
                                                                                                                                                        1. Others
                                                                                                                                                      2. Turkey
                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                      4. South Africa
                                                                                                                                                      5. Egypt
                                                                                                                                                      6. Nigeria
                                                                                                                                                      7. Rest of MEA
                                                                                                                                                    2. LATAM
                                                                                                                                                      1. LATAM Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                                                                                        1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                                                                                          1. Corticosteroids
                                                                                                                                                            1. Biologics
                                                                                                                                                            2. LATAM Anti-Inflammatory Therapeutics Market, By Indications
                                                                                                                                                              1. Arthritis
                                                                                                                                                                1. Psoriasis
                                                                                                                                                                  1. Respiratory Diseases
                                                                                                                                                                    1. Multiple Sclerosis
                                                                                                                                                                      1. Anti-inflammatory Bowel Disease
                                                                                                                                                                        1. Others
                                                                                                                                                                        2. Brazil
                                                                                                                                                                          1. Brazil Anti-Inflammatory Therapeutics Market, By Drug Class
                                                                                                                                                                            1. Nonsteroidal Anti-Inflammatory Drugs
                                                                                                                                                                              1. Corticosteroids
                                                                                                                                                                                1. Biologics
                                                                                                                                                                                2. Brazil Anti-Inflammatory Therapeutics Market, By Indications
                                                                                                                                                                                  1. Arthritis
                                                                                                                                                                                    1. Psoriasis
                                                                                                                                                                                      1. Respiratory Diseases
                                                                                                                                                                                        1. Multiple Sclerosis
                                                                                                                                                                                          1. Anti-inflammatory Bowel Disease
                                                                                                                                                                                            1. Others
                                                                                                                                                                                          2. Mexico
                                                                                                                                                                                          3. Argentina
                                                                                                                                                                                          4. Chile
                                                                                                                                                                                          5. Colombia
                                                                                                                                                                                          6. Rest of LATAM

                                                                                                                                                                                      Related Reports

                                                                                                                                                                                      Global Report
                                                                                                                                                                                      The global anti-VEGF therapeutics market size was valued at USD 12.3 billion in 2022. It is estimated to reach USD 13.7 billion by 2031, growing at a CAGR of 0.6% during the forecast period (2023–2031). The human body naturally produces VEGF,
                                                                                                                                                                                      Buy Now

                                                                                                                                                                                      Purchase Benefits

                                                                                                                                                                                      • Eligible for a free updated report next year
                                                                                                                                                                                      • Completely customizable scope
                                                                                                                                                                                      • 30% discount on your next purchase
                                                                                                                                                                                      • Dedicated account manager
                                                                                                                                                                                      • Query resolution within 24 hours
                                                                                                                                                                                      • Permission to print the report

                                                                                                                                                                                      We are featured on :

                                                                                                                                                                                      www.straitsresearch.com
                                                                                                                                                                                      © Copyright . All rights Reserved.